1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Advanced Biomedical Technologies, Inc.

Advanced Biomedical Technologies, Inc.

ABMT
Advanced Biomedical Technologies, Inc.US flagOther OTC
0.00
USD
- -
- -
50,000.00Market Cap
2008 Y
2009 Y
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
-0.01
-0.01
-0.01
-0.01
-0.02
-0.01
-0.02
-0.01
-0.01
-0.01
-0.01
-0.01
-0.01
Free Cash Flow per Basic Share
- -
-0.01
-0.01
- -
-0.01
-0.01
-0.01
-0.01
-0.01
-0.01
-0.01
-0.01
0.01
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
-0.03
-0.04
-0.05
-0.07
-0.08
-0.09
-0.11
-0.1
-0.11
-0.12
-0.14
-0.15
-0.15
Tangible Book Value per Share
- -
-0.02
-0.03
-0.03
-0.04
-0.05
-0.07
-0.08
-0.07
-0.07
-0.08
-0.09
-0.11
-0.12
Basic Weighted Avg Shares
- -
55
56
56
57
57
57
57
67
68
69
70
70
70
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-5,187.77
-259.59
-385.27
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
-1
-1
- -
-1
-1
-1
-1
-1
-1
-1
-1
-1
-1
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-8,139.49
-543.75
-685.68
Working Capital
-1
-1
-2
-2
-2
-3
-4
-5
-4
-5
-6
-7
-8
-8
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
-1
-1
-1
-2
-2
-3
-4
-4
-4
-5
-6
-6
-7
-8
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Jan'21
Apr'21
Jul'21
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
70
70
70
Market Capitalization
12
10
6

Working Capital

FRC

•

in mil. unless spec.
Jan'21
Apr'21
Jul'21
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
8
8
9
Payables & Accruals
8
8
9
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
18.02%
10.86%
14.26%
Free Cash Flow
-0.58%
-28.42%
-180.93%
Net Income, GAAP
1.75%
-2.48%
-29.18%
Sales/Revenue/Turnover
- -
- -
960.2%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2019
- -
- -
- -
- -
- -
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2019
- -
- -
- -
- -
-0.01
2020
- -
- -
- -
- -
-0.01
2021
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2019
- -
- -
- -
- -
- -
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Hui Wang
Full Time Employees
17
Sector
Healthcare
Industry
Medical - Devices
Address
200 Park Avenue New York City NY United States of America 10166
IPO Date
Mar 26, 2010
CIK
0001385799
Website
abtlafleur.com
Similar Companies
Contec Medical Systems Co.,Ltd (300869.SZ)
ENvizion Medical Ltd. (ENVM.TA)
Modular Medical, Inc. (MODD)
BioElectronics Corporation (BIEL)
Pharmacolog i Uppsala AB (publ) (PHLOG-B.ST)
GPX Medical AB (publ) (GPXMED.ST)
Business
Advanced Biomedical Technologies, Inc. (ABMT) designs, develops, manufactures, and markets biomaterial internal fixation devices and microcurrent therapy systems for medical applications. The company offers polymer osteosynthesis devices including surgical screws, binding wires, rods, and related instruments for orthopedic trauma treatment, sports-related injuries, cartilage repair, and reconstructive dental procedures; it also provides advanced microcurrent pain management systems such as the Electro-Acuscope 80T for neural stimulation and frequency integration in chronic pain control, Electro-Myopulse 75T for soft tissue therapy targeting muscles, ligaments, and tendons to reduce spasms and improve range of motion, LaFleur MX 2000 for anti-aging and esthetic applications in spas and cosmetology, and Neuroscope 230B for chronic pain, anxiety, stress, sleep disorders, and addiction management. Founded in 2002 and headquartered at 350 Fifth Avenue, 59th Floor, New York, New York, the company primarily serves doctors, clinicians, and healthcare professionals in the United States with a focus on development-stage innovations in health care equipment. ABMT, formerly known as Geostar Mineral Corporation, changed its name in March 2009 to reflect its shift to biomedical technologies; it operates as an authorized master distributor for its microcurrent devices through ABT-LaFleur, emphasizing clinical protocols developed over four decades with no reported adverse effects and sales exceeding 1,000 units across healthcare sectors.

Company News

APIChat

  • defenseworld.net

    NeuroPace (NASDAQ:NPCE) & Advanced Biomedical Technologies (OTCMKTS:ABMT) Head to Head Survey

  • defenseworld.net

    Comparing Advanced Biomedical Technologies (OTCMKTS:ABMT) and Veracyte (NASDAQ:VCYT)

  • defenseworld.net

    Reviewing Advanced Biomedical Technologies (OTCMKTS:ABMT) and Rapid Micro Biosystems (NASDAQ:RPID)